CN Stock MarketDetailed Quotes

600645 Vcanbio Cell & Gene Engineering Corp.,Ltd.

Watchlist
  • 16.72
  • +0.04+0.24%
Market Closed Jun 7 15:00 CST
7.82BMarket Cap71.76P/E (TTM)

About Vcanbio Cell & Gene Engineering Corp.,Ltd. Company

The company is an innovative life science enterprise with the vision of “precision medicine for the benefit of humanity”. The company focuses on the three major sectors of “precise prevention”, “accurate diagnosis” and “cell therapy”. Its main business covers the “precision medicine” industry chain, such as preparation and storage of cell testing, preparation and storage of in vitro diagnostic materials, in vitro diagnostic reagents and devices, scientific research reagent products such as biogenes, proteins, antibodies, etc., genetic testing services, and research and development of clinical applications of stem cells and immune cells. The company has advanced cell technology and a national cell resource storage network, and is one of the country's important cell technology product development and transformation bases. The company's main business includes preparation and storage of cell tests in the field of “precision prevention”; research and production of in vitro diagnostic materials, in vitro diagnostic reagents and devices in the field of “accurate diagnosis”, scientific research reagent products such as biogenes, proteins, antibodies, etc., and genetic testing services; research and development of clinical applications of stem cells and immune cells in the field of “precision therapy”; forming a “precision medicine” industry chain. The main products and services include: cell test preparation and storage services, in vitro diagnosis services: R&D, production, sales, and genetic testing services for in vitro diagnostic materials, biological genes, proteins, antibodies, pharmaceutical intermediates, and experimental complexes, including monoclonal antibodies and polyclonal antibody products. Company honors include the Vice Chairman Unit of the National Stem Cell and Regenerative Medicine Industry Technology Innovation Strategic Alliance, the Vice Chairman Unit of the Regenerative Medicine Professional Committee of the China Pharmaceutical Biotechnology Association, and the Blood Station Practice License.

Company Profile

Short Name-A中源协和
Symbol-A600645
Company NameZhongyuan Union Cell & Gene Engineering Corp., Ltd
Listing DateMay 4, 1993
Issue Price50.00
Shares Offered500.00K share(s)
FoundedJun 14, 1995
Listed ExchangeSH Stock Exchange
Legal Representativehongqi wang
General Managerhongqi wang
Secretaryxinzhe yang
Accounting FirmDahua Certified Public Accountants (Special General Partnership)
Securities Representativefen zhang
Legal CounselBeijing Guofeng Law Firm
Employees112
Phone022-58617160
Office AddressNo. 12, Meiyuan Road, Huayuan Industrial Park, Nankai District, Tianjin
Zip Code300384
Registered AddressTwo-story house, block [A], No. 12, Meiyuan Road, Huayuan Industrial Zone, Binhai High-tech Zone, Tianjin
Fax022-58617161
Emailzhongyuanxiehe@vcanbio.com
Business License120000000008313
BusinessGeneral projects: life science technology development; stem cell genetic engineering industrialization; investment activities with own capital; domestic trade agency; import and export of goods; technology import and export. (With the exception of projects subject to approval by law, independent business activities are carried out on the basis of a business license in accordance with the law)

Company Executives

  • Name
  • Position
  • Salary
  • hongjia gong
  • Chairman,directors
  • --
  • hongqi wang
  • Vice Chairman,directors,general manager
  • 419.30K
  • yong wang
  • Vice Chairman,directors
  • 1.93M
  • shan wu
  • directors
  • --
  • xu li
  • directors,Deputy General Manager
  • 1.07M
  • haibin li
  • directors,Deputy General Manager
  • 1.06M
  • xinyi hou
  • Independent directors
  • 100.00K
  • mingsheng luo
  • Independent directors
  • 62.90K
  • duanqing pei
  • Independent directors
  • 100.00K
  • xinzhe yang
  • Board Secretary,Deputy General Manager
  • 1.02M
  • fen zhang
  • Securities affairs representative
  • --
  • yan wang
  • Chairman of the Supervisory Board,auditors
  • --
  • xintong li
  • auditors
  • --
  • jiali zhou
  • Deputy General Manager
  • 977.30K
  • hongxiang shi
  • Deputy General Manager
  • 1.06M
  • yu zhang
  • Deputy General Manager
  • 2.42M
  • yiqing chen
  • Deputy General Manager,Chief Financial Officer
  • --
  • tianyi li
  • Employee supervisors
  • 191.90K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg